Treatment of the narcoleptiform sleep disorder in Chronic Fatigue Syndrome and fibromyalgia with sodium oxybate

Pain Practice

Volumn 10, Issue 1, 2010, Pages 54-59

  Spitzer, Robert A ^a   Broadman, Melissa ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Chronic Fatigue Syndrome; Fibromyalgia; Myofascial pain; Narcolepsy; Sodium oxybate

Indexed keywords

HLA DQB1 ANTIGEN; OXYBATE SODIUM;

ADULT; ANXIETY; ARTICLE; BEHAVIOR CHANGE; BLOOD PRESSURE; BULIMIA; CHRONIC FATIGUE SYNDROME; DIZZINESS; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG RESPONSE; DYSPNEA; FEMALE; FIBROMYALGIA; FOLLOW UP; GAIT DISORDER; HUMAN; INCONTINENCE; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MIGRAINE; NARCOLEPSY; NAUSEA; PARASOMNIA; PARESTHESIA; SIDE EFFECT; SLEEP APNEA SYNDROME; SLEEP DISORDER; SLEEP WALKING; SWELLING; WEIGHT REDUCTION;

EID: 77249131225     PISSN: 15307085     EISSN: 15332500     Source Type: Journal    
DOI: 10.1111/j.1533-2500.2009.00334.x     Document Type: Article

References (15)

1. Wolfe FSH, Yunus MB, Bennett RM, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum. 1990;33:160-172.
2. Centers for Disease Control and Prevention. Chronic Fatigue Syndrome. The revised case definition. http://www.cdc.gov/cfs/cfsdefinitionHCP.htm (accessed on October 24, 2009).
3. Centers for Disease Control and Prevention. Chronic Fatigue Syndrome. Possible causes. http://www.cdc.gov/cfs/cfscauses.htm (accessed on October 24, 2009).
4. Gur A, Oktayoglu P. Central nervous system abnormalities in fibromyalgia and chronic fatigue syndrome: new concepts in treatment. Curr Pharm Des. 2008;14:1274-1294.
5. U.S. Xyrem Multicenter Study Group. A randomized, double blind, placebo-controlled multi-center trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy. Sleep. 2002;25:42-49.
6. U.S. Xyrem Multicenter Study Group. Sodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsy. Sleep Med. 2004;5:119-123.
7. Xyrem International Study Group. Further evidence supporting the use of sodium oxybate for the treatment of cataplexy: a double-blind, placebo-controlled study in 228 patients. Sleep Med. 2005;6:415-421.
8. Xyrem International Study Group. A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy. J Clin Sleep Med. 2005;1:391-397.
9. Black J, Houghton WC. Sodium oxybate improves excessive daytime sleepiness in narcolepsy. Sleep. 2006;29: 939-946.
10. Scharf MB, Hauck M, Stover R, et al. Effect of Gamma-hydroxybutyrate on pain, fatigue, and the alpha sleep anomaly in patients with fibromyalgia. Preliminary report. J Rheumatol. 1998;25:1986-1990.
11. Scharf MB, Baumann M, Berkowitz DV. The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia. J Rheumatol. 2003;30:1070-1074.
12. Crofford LJ, Mease PJ, Simpson SL, et al. Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6 month double-blind, placebo controlled trial with pregabalin. Pain. 2008;136:419-431.
13. Arnold LM, Lu Y, Crofford LJ, et al. A doubleblind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum. 2004;50:2974-2984.
14. Arnold L, Rosen A, Pritchett Y, et al. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain. 2005;119:5-15.
15. Russell IJ, Perkins AT, Michalek JE; Oxybate SXB-26 Fibromyalgia Syndrome Study Group. Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial. Arthritis Rheum. 2009;60:299-309.